Thus, our finding that NFAs downregulate total Cat S activity via both PPARγ- and electrophile-dependent mechanisms, while others found NFAs downregulate MMP expression [24], points to a potentially important protective role of endogenous or therapeutically-aimed NFAs in COPD (Fig 7). This evidence concerns the gene CAT and chronic obstructive pulmonary disease.